We are live on
!
Find out more
BNP Paribas Asset Management Portfolio holdings
AUM
$86.1B
1-Year Est. Return
29.11%
This Fund
S&P 500
This Quarter
Est. Return
-2.17%
1 Year Est. Return
+29.11%
3 Year Est. Return
+87.64%
5 Year Est. Return
+102.48%
10 Year Est. Return
+408.22%
AUM
$86.1B
AUM Growth
-$1.05B
(-1.2%)
Cap. Flow
+$4.86B
Cap. Flow
% of AUM
5.64%
Top 10 Holdings %
Top 10 Hldgs %
27.63%
Holding
2,366
New
101
Increased
1,396
Reduced
686
Closed
108
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$1.43B |
| 2 |
TotalEnergies
TTE
|
+$626M |
| 3 |
Deutsche Bank
DB
|
+$326M |
| 4 |
Stellantis
STLA
|
+$263M |
| 5 |
Broadcom
AVGO
|
+$237M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ciena
CIEN
|
+$291M |
| 2 |
Apple
AAPL
|
+$262M |
| 3 |
Amazon
AMZN
|
+$219M |
| 4 |
Tesla
TSLA
|
+$205M |
| 5 |
Meta Platforms (Facebook)
META
|
+$197M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.22% |
| 2 | Healthcare | 13.97% |
| 3 | Financials | 10.51% |
| 4 | Consumer Discretionary | 10.09% |
| 5 | Industrials | 8.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
V2X
VVX
$2.62B
| $41.6K | ﹤0.01% |
607
+155
| +34% | +$10.5K |
|
1727
Levi Strauss
LEVI
$9.44B
| $41.3K | ﹤0.01% |
2,234
+592
| +36% | +$12.1K |
|
1728
Travere Therapeutics
TVTX
$5.33B
| $41.3K | ﹤0.01% |
1,390
+288
| +26% | +$8.61K |
|
1729
nLIGHT
LASR
$3.95B
| $41.2K | ﹤0.01% |
723
+164
| +29% | +$8.89K |
|
1730
S&T Bancorp
STBA
$1.86B
| $41K | ﹤0.01% |
981
+333
| +51% | +$13.9K |
|
1731
Lionsgate Studios
LION
$3.88B
| $40.9K | ﹤0.01% |
+4,261
| New | +$39.3K |
|
1732
10x Genomics
TXG
$5.87B
| $40.6K | ﹤0.01% |
+1,912
| New | +$38.2K |
|
1733
Exponent
EXPO
$2.98B
| $40.6K | ﹤0.01% |
622
+102
| +20% | +$7.25K |
|
1734
Melco Resorts & Entertainment
MLCO
$2.1B
| $40.6K | ﹤0.01% |
7,144
-60,619
| -89% | -$367K |
|
1735
Universal Technical Institute
UTI
$2.08B
| $40.4K | ﹤0.01% |
1,119
+265
| +31% | +$8.36K |
|
1736
NBT Bancorp
NBTB
$2.72B
| $40.3K | ﹤0.01% |
947
+273
| +41% | +$11.8K |
|
1737
ProPetro Holding
PUMP
$1.45B
| $40.2K | ﹤0.01% |
2,789
+724
| +35% | +$8.66K |
|
1738
Huntsman Corp
HUN
$2.24B
| $39.9K | ﹤0.01% |
3,001
+809
| +37% | +$9.8K |
|
1739
Vita Coco
COCO
$3.77B
| $39.9K | ﹤0.01% |
833
+212
| +34% | +$11.6K |
|
|
UNIT
1740
Uniti Group
UNIT
$2.63B
| $39.9K | ﹤0.01% |
4,253
-20,581
| -83% | -$161K |
|
|
NPKI
1741
NPK International
NPKI
$1.21B
| $39.5K | ﹤0.01% |
2,728
+1,728
| +173% | +$24K |
|
1742
Peoples Bancorp
PEBO
$1.45B
| $39.4K | ﹤0.01% |
1,199
+454
| +61% | +$14.6K |
|
1743
Oscar Health
OSCR
$8.5B
| $39.4K | ﹤0.01% |
3,434
+724
| +27% | +$10.2K |
|
1744
Atkore
ATKR
$2.59B
| $39.4K | ﹤0.01% |
668
+168
| +34% | +$10.9K |
|
1745
Chefs' Warehouse
CHEF
$3.87B
| $39.3K | ﹤0.01% |
661
+177
| +37% | +$11.3K |
|
1746
Goodyear
GT
$2.07B
| $39.2K | ﹤0.01% |
5,918
+1,748
| +42% | +$14.7K |
|
1747
Sarepta Therapeutics
SRPT
$1.66B
| $39.1K | ﹤0.01% |
1,795
+471
| +36% | +$9.12K |
|
1748
Tarsus Pharmaceuticals
TARS
$2.56B
| $38.8K | ﹤0.01% |
553
+120
| +28% | +$8.38K |
|
1749
Sable Offshore Corp
SOC
$903M
| $38.8K | ﹤0.01% |
2,348
+440
| +23% | +$5.14K |
|
1750
Worthington Enterprises
WOR
$2.76B
| $38.7K | ﹤0.01% |
743
+205
| +38% | +$11K |
|
Similar funds
BNP Paribas Asset Management's Q1 2026 Portfolio in Review
As of Q1 2026, BNP Paribas Asset Management held 2,366 positions worth $86.1B, down 1.2% from $87.2B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
BNP Paribas Asset Management deployed $4.86B of net new capital in Q1 2026, opening 101 new positions and adding to 1,396 existing holdings. Its largest new stake was Viking Holdings: 1,864,036 shares worth $137M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 37% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Ciena, an estimated $291M trimmed.
- BNP Paribas Asset Management's largest Q1 2026 buy was Viking Holdings: 1,864,036 shares worth $137M.
- BNP Paribas Asset Management added most to AstraZeneca in Q1 2026, an estimated $1.43B increase.
- BNP Paribas Asset Management's biggest Q1 2026 reduction was Ciena, cutting an estimated $291M.
- BNP Paribas Asset Management fully exited Exact Sciences in Q1 2026, selling an estimated $35.9M.
- BNP Paribas Asset Management's ten largest holdings make up 28% of its $86.1B portfolio in Q1 2026.
- BNP Paribas Asset Management opened 101 new positions and closed 108 in Q1 2026.
- BNP Paribas Asset Management's portfolio value fell 1.2% quarter-over-quarter to $86.1B.
Based on BNP Paribas Asset Management's 13F filing for Q1 2026, filed 14 May 2026.